Medivolve Inc. (4NC.F)

Medivolve Inc. (4NC.F) — VMCI valuation read

Across 120 indicators, Medivolve Inc. (4NC.F) lands at VMCI 33/100. The Healthcare sector median is 50, so the 17-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 4NC.F in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 4NC.F trades at 17.0x earnings, 6% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 0.0x leaves covenant headroom for 4NC.F on the trailing balance sheet.

4NC.F rose 3.4% over the trailing 7 days, with a +1.0% read on a 30-day basis.